PAHC - Phibro Animal Health Corporation
NEXT EARNINGS:
May 6, 2026
EPS Est: $0.72
|
Rev Est: $365.2M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$49.00
DETAILS
HIGH:
$49.00
LOW:
$49.00
MEDIAN:
$49.00
CONSENSUS:
$49.00
DOWNSIDE:
4.78%
Market Cap:
2.09B
Volume:
201,843
Avg Volume:
268,245
52 Week Range:
16.16-56.3
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
0.80
Last Dividend:
$0.48
Exchange:
NASDAQ
Country:
US
Employees:
1,940
IPO Date:
2014-04-11
EPS (TTM):
1.19
P/E Ratio:
21.43
Revenue (TTM):
1.30B
Total Assets:
1.36B
Total Debt:
761.55M
Cash & Equiv:
68.04M
Rev Growth (5Y):
10.1%
EPS Growth (5Y):
7.5%
FCF Growth (5Y):
10.6%
ROCE:
9.5%
Debt/Equity:
2.67
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $0.87 | $0.69 | +26.1% | $373.9M | $365.2M | +2.4% |
| 2025-11-05 | $0.73 | $0.59 | +23.7% | $363.9M | $345.4M | +5.3% |
| 2025-08-27 | $0.57 | $0.52 | +9.6% | $378.7M | $362.4M | +4.5% |
| 2025-05-07 | $0.63 | $0.52 | +21.2% | $347.8M | $362.2M | -4.0% |
| 2025-02-05 | $0.54 | $0.40 | +35.0% | $309.3M | $347.0M | -10.9% |
| 2024-11-07 | $0.35 | $0.25 | +40.0% | $260.4M | $244.4M | +6.6% |
| 2024-08-28 | $0.41 | $0.34 | +20.6% | $273.2M | $263.2M | +3.8% |
| 2024-05-08 | $0.31 | $0.29 | +6.9% | $263.2M | $263.2M | 0.0% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.30B | 1.02B | 977.89M | 942.26M | 833.35M | 800.35M | 828.00M | 820.00M | 764.30M | 751.50M | 748.59M | 691.90M |
| Net Income | 48.26M | 2.42M | 32.61M | 49.17M | 54.38M | 33.55M | 54.70M | 64.90M | 64.60M | 82.70M | 60.28M | (3.10M) |
| EPS | 1.19 | 0.06 | 0.81 | 1.21 | 1.34 | 0.83 | 1.35 | 1.61 | 1.63 | 2.11 | 1.55 | -0.10 |
| Total Assets | 1.36B | 982.18M | 971.40M | 931.70M | 841.33M | 784.10M | 726.67M | 671.68M | 623.40M | 610.37M | 493.32M | 472.32M |
| Total Debt | 761.55M | 525.46M | 509.97M | 470.48M | 426.71M | 410.72M | 326.18M | 312.38M | 313.14M | 352.71M | 289.52M | 289.39M |
| Cash & Equivalents | 68.04M | 70.61M | 41.28M | 74.25M | 50.21M | 36.34M | 57.57M | 29.17M | 56.08M | 33.60M | 29.22M | 11.82M |
| Operating Cash Flow | 80.12M | 87.59M | 13.31M | 31.65M | 48.31M | 59.35M | 47.17M | 70.01M | 98.40M | 37.22M | 68.70M | (712,000) |
| Free Cash Flow | 41.83M | 46.36M | (38.48M) | (5.39M) | 18.99M | 25.30M | 17.28M | 51.46M | 77.50M | 866,000 | 48.65M | (20.56M) |
| FCF per Share | 1.03 | 1.14 | -0.95 | -0.13 | 0.47 | 0.62 | 0.43 | 1.28 | 1.96 | 0.02 | 1.25 | -0.66 |
| Book Value | 285.68M | 256.64M | 282.51M | 262.44M | 238.53M | 188.20M | 216.01M | 184.95M | 151.16M | 90.48M | 29.63M | 15.15M |
| Cash & ST Investments | 77.04M | 114.61M | 81.28M | 91.25M | 93.21M | 91.34M | 81.57M | 79.17M | 56.08M | 33.60M | 29.22M | 11.82M |
| ROC Equity | 0.17 | 0.01 | 0.12 | 0.19 | 0.23 | 0.18 | 0.25 | 0.35 | 0.43 | 0.91 | 2.03 | -0.20 |